CEPR researches how US government-granted monopolies of patents, copyrights, and other forms of intellectual property redistribute income upward and the role of digital global trade and international commercial agreements on inequality and economic mobility.
CEPR investiga cómo los monopolios de patentes, derechos de autor y otras formas de propiedad intelectual otorgados por el gobierno de los Estados Unidos redistribuyen el ingreso hacia arriba. CEPR analiza el papel del comercio mundial digital y los acuerdos comerciales internacionales sobre desigualdad y movilidad económica.
CEPR researches how US government-granted monopolies of patents, copyrights, and other forms of intellectual property redistribute income upward and the role of digital global trade and international commercial agreements on inequality and economic mobility.
CEPR investiga cómo los monopolios de patentes, derechos de autor y otras formas de propiedad intelectual otorgados por el gobierno de los Estados Unidos redistribuyen el ingreso hacia arriba. CEPR analiza el papel del comercio mundial digital y los acuerdos comerciales internacionales sobre desigualdad y movilidad económica.
· Op-Ed/Commentary
COVID-19Intellectual Property The Neanderthal Protectionists at the Washington Post Don’t Care About Getting the World VaccinatedDean Baker / May 04, 2021
· Op-Ed/Commentary
COVID-19InequalityIntellectual Property Patents and the Pandemic: Can We Learn Anything?Dean Baker / April 12, 2021
· Op-Ed/Commentary
COVID-19Economic Crisis and RecoveryIntellectual Property A Vaccine Summit: Taking the Pandemic SeriouslyDean Baker / April 09, 2021
· Op-Ed/Commentary
Economic Crisis and RecoveryEconomic GrowthGovernmentIntellectual Property Quick, How Much Is $2 Trillion?Dean Baker / March 31, 2021
· Op-Ed/Commentary
Globalization and TradeInequalityIntellectual Property Free Trade and Free Taxes: How Our Intellectuals Help the RichDean Baker / March 30, 2021
· Op-Ed/Commentary
Intellectual Property More on Open-Source Versus Patent Monopoly Financing of Drug DevelopmentDean Baker / March 24, 2021
· Op-Ed/Commentary
Economic Crisis and RecoveryIntellectual Property The Debt Whiners: Fools or Liars?Dean Baker / March 22, 2021
· Op-Ed/Commentary
COVID-19InequalityIntellectual Property New York Times Does Public Relations Work for the Pharmaceutical IndustryDean Baker / March 21, 2021
· Op-Ed/Commentary
COVID-19Economic Crisis and RecoveryIntellectual Property Thomas Cueni, Director General of the International Pharma Trade Association, Calls Bill Gates a MoronDean Baker / March 17, 2021
· Op-Ed/Commentary
COVID-19Economic Crisis and RecoveryInequalityIntellectual Property The New York Times Has not Heard of China’s (or Russia’s) VaccinesDean Baker / March 04, 2021
